Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 10KSB Other 10KSB
  2. S-2/A Other S-2/A
  3. 10QSB/A Other 10QSB/A
  4. 10KSB/A Other 10KSB/A
  5. 8-K Event Item 1
  6. 3 Insider Initial Statement of Ownership
  7. SC 13D Stake Beneficial Ownership Report
  8. 8-K Event Item 1
  9. 8-K Event Item 1
  10. S-2 Other S-2
  11. 8-K Event Item 5
  12. 10QSB/A Other 10QSB/A
  13. 10QSB Other 10QSB
  14. SC 13D/A Stake Beneficial Ownership Report
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 10QSB Other 10QSB
  17. DEF 14A Proxy Proxy Statement
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. 10QSB Other 10QSB
  20. 10KSB/A Other 10KSB/A

Page 70 of 72 · 1,429 filings